We developed a fibroblast-targeted AAV9 system featuring FSP1 promoter-driven expression of HYBID-targeting shRNA to specifically examine HYBID’s role in myocardial fibrosis and ventricular remodeling [28,29]. Here, CEMIP is linked to Myocardial fibrosis.